HCP

Book a presentation with our prebiotic experts.

With consumer demand for gut health solutions rising, at Clasado Biosciences, we make it easier than ever for formulators and product designers like you to create scientifically backed products featuring prebiotics that connect with this need.

As a leading name in galactooligosaccharide (GOS) prebiotic science, we’re committed to supporting brands across the health and nutrition sector to deliver clinically proven prebiotic solutions that enhance human health and well-being.

The most studied ingredient of its kind, Bimuno® GOS is found in health and nutrition products around the globe, from supplements to support everyday gut health1,2 to immune health3,4 and cognitive health5,6. Bimuno GOS is used in a wide variety of applications, including supplements, medical nutrition, chewable gummies, functional food and beverage products, sports health products and synbiotics.

Do you require high scientific standards for your formulations? Then make our award-winning Bimuno GOS your prebiotic of choice.

115+ publications

20+ clinical studies

Low daily dose (1.37g active GOS)

Unique GOS structure

Health claims available*

Complete our contact form below and our team will be in touch to arrange a one-to-one session at your convenience, covering how we can support the key health areas that matter to your business.

Formulation excellence starts with a dedicated one to one, where our experienced team can explain how the benefits of choosing Bimuno GOS translate to real-world advantages for your health product.

Its scientific backing of more than 115 scientific publications marks it out as an efficacious choice for health and nutrition products that target gastrointestinal or digestive health, immune support, cognitive health and athletic health.

* In select geographies, products containing Bimuno GOS can utilise supporting health claims and/ or statements. We’ll be happy to share what is available specific to your territory on request

  1. Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. 2009. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 1;29(5):508-18. DOI:10.1111/j.1365-2036.2008.03911.x
  2. Huaman JW, Mego M, Manichanh Ch et al. 2018. Effects Of Prebiotics Vs A Diet Low In Fodmaps In Patients With Functional Gut Disorder. Gastroenterology. 155(4):1004-1007. DOI:10.1053/j.gastro.2018.06.045
  3. Hasle G, Raastad R, Bjune, G, Jenum PA, Heier L. 2017. Can a galacto-oligosaccharide reduce the risk of traveller’s diarrhoea? A placebo-controlled, randomized, double-blind study. J Travel Med. 24(5);1-9. DOI:10.1093/jtm/tax057
  4. Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR. 2008. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr. 88(5):1438-46. DOI: 10.3945/ajcn.2008.26242
  5. Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. 2009. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 1;29(5):508-18. DOI:10.1111/j.1365-2036.2008.03911.x
  6. Kao AC, Safarikova J, Marquardt T, Mullins B, Lennox BR, Burnet PWJ. 2019. Pro-cognitive effect of a prebiotic in psychosis: A double blind placebo controlled cross-over study. Schizophr Res. pii: S0920-9964(19)30085-4. DOI:10.1016/j.schres.2019.03.003